Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1708 ARTÍCULOS , VIENDO DEL 1696 AL 1708

Relationship between long non-coding RNAs and Alzheimer's disease: a systematic review

Chen L, Guo X, Li Z, He Y.

Pathol Res Pract. 2019 Jan;215(1):12-20. doi: 10.1016/j.prp.2018.11.012. Epub 2018 Nov 13.

Auditory and visual hallucination prevalence in Parkinson's disease and dementia with Lewy bodies: a systematic review and meta-analysis

Eversfield CL, Orton LD.

Psychol Med. 2019 Oct;49(14):2342-2353. doi: 10.1017/S0033291718003161. Epub 2018 Nov 26.

Implications of Successful Symptomatic Treatment in Parkinson's Disease for Therapeutic Strategies of Alzheimer's Disease

Zhao L, Cheng X, Zhong C.

ACS Chem Neurosci. 2019 Feb 20;10(2):922-930. doi: 10.1021/acschemneuro.8b00450. Epub 2018 Dec 12.

The role of de novo mutations in adult-onset neurodegenerative disorders

Nicolas G, Veltman JA.

Acta Neuropathol. 2019 Feb;137(2):183-207. doi: 10.1007/s00401-018-1939-3. Epub 2018 Nov 26.

Vitamin D basis of Alzheimer's disease: from genetics to biomarkers

Dursun E, Gezen-Ak D.

Hormones (Athens). 2019 Mar;18(1):7-15. doi: 10.1007/s42000-018-0086-5. Epub 2018 Nov 27.

Functions and dysfunctions of nitric oxide in brain

Picón-Pagès P, Garcia-Buendia J, Muñoz FJ.

Biochim Biophys Acta Mol Basis Dis. 2019 Aug 1;1865(8):1949-1967. doi: 10.1016/j.bbadis.2018.11.007. Epub 2018 Nov 27.

Apolipoprotein E Polymorphisms and Parkinson Disease With or Without Dementia: A Meta-Analysis Including 6453 Participants

Sun R, Yang S, Zheng B, Liu J, Ma X.

J Geriatr Psychiatry Neurol. 2019 Jan;32(1):3-15. doi: 10.1177/0891988718813675. Epub 2018 Dec 9.

A comparison of visual hallucinations across disorders

Dudley R, Aynsworth C, Mosimann U, Taylor JP, Smailes D, Collerton D, McCarthy-Jones S, Urwyler P.

Psychiatry Res. 2019 Feb;272:86-92. doi: 10.1016/j.psychres.2018.12.052. Epub 2018 Dec 8.

Elimination of amyloid precursor protein in senile plaques in the brain of a patient with Alzheimer-type dementia and Down syndrome

Arai Y, Iwasaki Y, Suzuki T, Ide S, Kaga M.

Brain Dev. 2019 Jan;41(1):106-110. doi: 10.1016/j.braindev.2018.07.017. Epub 2018 Aug 4.

CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity

Parsons CG.

Neuropharmacology. 2019 Mar 15;147:4-10. doi: 10.1016/j.neuropharm.2018.08.027. Epub 2018 Aug 27.

Predictors of simulated driving performance in Huntington's disease

Jacobs M, Hart EP, Mejia Miranda Y, Groeneveld GJ, van Gerven JMA, Roos RAC.

Parkinsonism Relat Disord. 2019 Mar;60:64-69. doi: 10.1016/j.parkreldis.2018.10.002. Epub 2018 Oct 1.

A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease

Rahman SO, Singh RK, Hussain S, Akhtar M, Najmi AK.

Eur J Pharmacol. 2019 Jan 5;842:208-220. doi: 10.1016/j.ejphar.2018.10.040. Epub 2018 Oct 30.

Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy

Doyle KL, Woods SP, McDonald CR, Leyden KM, Holden HM, E Morgan E, Gilbert PE, Corey-Bloom J.

Appl Neuropsychol Adult. 2019 Jan-Feb;26(1):17-27. doi: 10.1080/23279095.2017.1353993. Epub 2017 Aug 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias